**Abstract**

**Background:** N-Methyl-D-aspartate (NMDA) receptor hypofunction may contribute to the pathophysiology of schizophrenia. Clozapine, a highly effective treatment for schizophrenia, targets serotonin 2C receptors (5-HT2CR) with high affinity. 5-HT2CR modulate dopamine release. The interaction between 5-HT2CR and dopamine in an NMDA receptor hypofunctional condition, however, is not fully understood. We evaluated 5-HT2CR function for dopamine levels in an NMDA receptor antagonist-induced rat model of schizophrenia.

**Method:** Schizophrenia model rats were treated chronically the NMDA receptor antagonist MK-801. We prepared four groups: 1) Naïve rats with single administration of MK-212; 5-HT2CR agonist, 2) Naïve rats with single administration of MK-801, 3) Chronically MK-801-treated rats with single administration of MK-212, and 4) Chronically MK-801-treated rats with single administration of MK-801. Extracellular dopamine levels in the prefrontal cortex (PFC) were measured using *in vivo microdialysis*. An open field test was used for behavioral assessment

**Results:** The PFC dopamine level was significantly increased by single administration of MK-801 in naïve rats, but not in chronically MK-801-treated rats. The PFC dopamine level was not affected by single MK-212 administration in naïve rats, but was significantly increased in chronically MK-801-treated rats. Total distance traveled in the open field test tended to be increased by single MK-801 administration in naïve rats, and was significantly increased in chronically MK-801-treated rats. It was not affected by single MK-212 administration in naïve or chronically MK-801-treated rats.

**Conclusion:** These findings indicate that function of 5-HT2CR is altered to regulate excitatory the PFC dopamine in NMDA receptor hypofunctional condition.
